Analyst Yee holds a meeting with CEO Mahoney in New York on October 22 hosted by Jefferies.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRDN:
- Viridian Therapeutics CEO buys $499.3K in common stock
- Viridian Therapeutics price target raised to $61 from $56 at BTIG
- Largest borrow rate increases among liquid names
- Viridian Therapeutics price target raised to $44 from $35 at RBC Capital
- Viridian Therapeutics 10.67M share Secondary priced at $18.75